ArticleFrontiers in oncology2022

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy.

Hongyu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.